Annual Accounts Payable
$15.66 M
+$2.43 M+18.38%
31 December 2023
Summary:
ADMA Biologics annual accounts payable is currently $15.66 million, with the most recent change of +$2.43 million (+18.38%) on 31 December 2023. During the last 3 years, it has risen by +$3.23 million (+25.99%). ADMA annual accounts payable is now at all-time high.ADMA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$16.02 M
+$1.84 M+12.98%
30 September 2024
Summary:
ADMA Biologics quarterly accounts payable is currently $16.02 million, with the most recent change of +$1.84 million (+12.98%) on 30 September 2024. Over the past year, it has increased by +$360.00 thousand (+2.30%). ADMA quarterly accounts payable is now -36.42% below its all-time high of $25.20 million, reached on 30 September 2022.ADMA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMA Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +2.3% |
| 3 y3 years | +26.0% | +28.9% |
| 5 y5 years | +70.7% | +74.6% |
ADMA Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +26.0% | -36.4% | +47.6% |
| 5 y | 5 years | at high | +70.7% | -36.4% | +159.8% |
| alltime | all time | at high | +1379.2% | -36.4% | +3048.0% |
ADMA Biologics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $16.02 M(+13.0%) |
| June 2024 | - | $14.18 M(-17.5%) |
| Mar 2024 | - | $17.19 M(+9.7%) |
| Dec 2023 | $15.66 M(+18.4%) | $15.66 M(+44.3%) |
| Sept 2023 | - | $10.85 M(-10.2%) |
| June 2023 | - | $12.08 M(-6.7%) |
| Mar 2023 | - | $12.96 M(-2.1%) |
| Dec 2022 | $13.23 M(+6.4%) | $13.23 M(-47.5%) |
| Sept 2022 | - | $25.20 M(+121.3%) |
| June 2022 | - | $11.39 M(-19.3%) |
| Mar 2022 | - | $14.12 M(+13.6%) |
| Dec 2021 | $12.43 M(+12.2%) | $12.43 M(-28.1%) |
| Sept 2021 | - | $17.28 M(+180.2%) |
| June 2021 | - | $6.17 M(-49.3%) |
| Mar 2021 | - | $12.15 M(+9.7%) |
| Dec 2020 | $11.07 M(+20.7%) | $11.07 M(+38.8%) |
| Sept 2020 | - | $7.98 M(+15.5%) |
| June 2020 | - | $6.91 M(-24.5%) |
| Mar 2020 | - | $9.15 M(-0.2%) |
| Dec 2019 | $9.17 M(+55.5%) | $9.17 M(+2.4%) |
| Sept 2019 | - | $8.96 M(+32.0%) |
| June 2019 | - | $6.79 M(+23.9%) |
| Mar 2019 | - | $5.48 M(-7.1%) |
| Dec 2018 | $5.90 M | $5.90 M(+12.0%) |
| Sept 2018 | - | $5.27 M(+69.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $3.10 M(-45.8%) |
| Mar 2018 | - | $5.72 M(-3.4%) |
| Dec 2017 | $5.92 M(+130.9%) | $5.92 M(-35.3%) |
| Sept 2017 | - | $9.16 M(+96.0%) |
| June 2017 | - | $4.67 M(+19.7%) |
| Mar 2017 | - | $3.90 M(+52.2%) |
| Dec 2016 | $2.56 M(+22.8%) | $2.56 M(-7.7%) |
| Sept 2016 | - | $2.78 M(-16.3%) |
| June 2016 | - | $3.32 M(+34.4%) |
| Mar 2016 | - | $2.47 M(+18.2%) |
| Dec 2015 | $2.09 M(+17.4%) | $2.09 M(-4.4%) |
| Sept 2015 | - | $2.18 M(+32.6%) |
| June 2015 | - | $1.65 M(-7.4%) |
| Mar 2015 | - | $1.78 M(-0.0%) |
| Dec 2014 | $1.78 M(-34.3%) | $1.78 M(-27.2%) |
| Sept 2014 | - | $2.44 M(+4.5%) |
| June 2014 | - | $2.34 M(-15.3%) |
| Mar 2014 | - | $2.76 M(+2.0%) |
| Dec 2013 | $2.71 M(+155.9%) | $2.71 M(+82.8%) |
| Sept 2013 | - | $1.48 M(+27.9%) |
| June 2013 | - | $1.16 M(-16.0%) |
| Mar 2013 | - | $1.38 M(+30.3%) |
| Dec 2012 | $1.06 M | $1.06 M(+18.8%) |
| Sept 2012 | - | $890.80 K(+12.6%) |
| June 2012 | - | $790.90 K(+55.4%) |
| Mar 2012 | - | $508.90 K |
FAQ
- What is ADMA Biologics annual accounts payable?
- What is the all time high annual accounts payable for ADMA Biologics?
- What is ADMA Biologics quarterly accounts payable?
- What is the all time high quarterly accounts payable for ADMA Biologics?
- What is ADMA Biologics quarterly accounts payable year-on-year change?
What is ADMA Biologics annual accounts payable?
The current annual accounts payable of ADMA is $15.66 M
What is the all time high annual accounts payable for ADMA Biologics?
ADMA Biologics all-time high annual accounts payable is $15.66 M
What is ADMA Biologics quarterly accounts payable?
The current quarterly accounts payable of ADMA is $16.02 M
What is the all time high quarterly accounts payable for ADMA Biologics?
ADMA Biologics all-time high quarterly accounts payable is $25.20 M
What is ADMA Biologics quarterly accounts payable year-on-year change?
Over the past year, ADMA quarterly accounts payable has changed by +$360.00 K (+2.30%)